Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -732,938 | -543,347 | -653,251 | -484,652 | -586,454 |
| Depreciation Amortization | 11,401 | 13,539 | 15,401 | 6,771 | 5,843 |
| Accounts receivable | -134,722 | -2,971 | 15,328 | N/A | N/A |
| Accounts payable and accrued liabilities | 26,609 | 1,512 | 2,780 | -349 | 2,833 |
| Other Working Capital | -51,064 | 32,042 | 5,057 | 28,079 | -4,396 |
| Other Operating Activity | 434,804 | -21,501 | 86,965 | 30,657 | 84,240 |
| Operating Cash Flow | $-445,910 | $-520,726 | $-527,720 | $-419,494 | $-497,934 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,097 | -933 | -1,306 | -4,821 | -13,246 |
| Purchase Of Investment | -28,197 | -114,082 | -137,264 | -193,055 | -643,275 |
| Sale Of Investment | 11,000 | 158,229 | 193,106 | 532,523 | 477,041 |
| Purchase Sale Intangibles | -8,495 | -7,975 | N/A | -1,500 | -35,000 |
| Other Investing Activity | -6,193 | 17,567 | -503 | 118,500 | -21,346 |
| Investing Cash Flow | $-24,487 | $60,781 | $54,033 | $453,147 | $-200,826 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 747,500 |
| Debt Issued | 575,000 | 450,000 | N/A | N/A | 456,296 |
| Debt Repayment | -459,000 | -473,417 | N/A | -20,486 | -124,119 |
| Common Stock Issued | 34,149 | 322,899 | 459,216 | 8,076 | 20,464 |
| Common Stock Repurchased | -62,502 | -7,526 | -6,880 | -1,561 | -266,041 |
| Other Financing Activity | 271,646 | 456,501 | -801 | 837 | -97,654 |
| Financing Cash Flow | $359,293 | $748,457 | $451,535 | $-13,134 | $736,446 |
| Beginning Cash Position | 683,244 | 394,732 | 416,884 | 396,365 | 358,679 |
| End Cash Position | 572,140 | 683,244 | 394,732 | 416,884 | 396,365 |
| Net Cash Flow | $-111,104 | $288,512 | $-22,152 | $20,519 | $37,686 |
| Free Cash Flow | |||||
| Operating Cash Flow | -445,910 | -520,726 | -527,720 | -419,494 | -497,934 |
| Capital Expenditure | -1,097 | -933 | -1,306 | -4,821 | -13,246 |
| Free Cash Flow | -447,007 | -521,659 | -529,026 | -424,315 | -511,180 |